Study guide

Section 8.1: Texas Prescription Monitoring Program Reporting & Database

Texas MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacy Law Foundations & Regulators

Section 1.1: State and Federal Regulatory Bodies Section 1.2: Structure of Texas Pharmacy Law Section 1.3: TSBP Powers and Administrative Procedures Section 1.4: Inspections, Investigations, and Discipline

2 Chapter 2: Pharmacist Licensure & Continuing Education

Section 2.1: Initial Pharmacist Licensure & Reciprocity Section 2.2: License Renewal & Continuing Education Requirements Section 2.3: Inactive Status, Reinstatement, and Administrative Changes Section 2.4: Impaired Pharmacists & Peer Review Programs

3 Chapter 3: Pharmacy Personnel & Supervision Ratios

Section 3.1: Pharmacist-in-Charge (PIC) Responsibilities and Duties Section 3.2: Pharmacy Technicians and Technician Trainees Section 3.3: Pharmacist-to-Technician Supervision Ratios Section 3.4: Duties of Supportive Personnel

4 Chapter 4: Pharmacy Permits & Facility Classifications

Section 4.1: Texas Pharmacy Permit Classes Section 4.2: Class A (Community) Operations & Facilities Section 4.3: Class C (Institutional/Hospital) Operations & Facilities Section 4.4: Central Processing (Class G) and Non-Resident (Class E)

5 Chapter 5: Prescribers & Prescription Validity

Section 5.1: Texas Prescriptive Authority Section 5.2: General Prescription Requirements Section 5.3: Out-of-State and Canadian/Mexican Prescriptions Section 5.4: Self-Prescribing & Prescribing for Family Members

6 Chapter 6: Controlled Substances Schedules & Registration

Section 6.1: Federal vs. Texas Controlled Substances Schedules Section 6.2: DEA Registration & Texas Controlled Substances Act Section 6.3: Scheduled Listed Chemical Products Section 6.4: Controlled Substance Theft or Loss Reporting

7 Chapter 7: Controlled Substances Prescriptions & Dispensing

Section 7.1: CII Prescription Requirements and Validity Section 7.2: CII Refills, Partial Fills, and Emergency Oral Dispensing Section 7.3: CIII-CV Prescription Requirements, Validity, Refills, and Partial Fills Section 7.4: Opioid 10-day Initial Supply Limit & PMP Mandatory Queries

8 Chapter 8: Prescription Monitoring Program (PMP) & Drug Abuse

Section 8.1: Texas Prescription Monitoring Program Reporting & Database Section 8.2: Naloxone Access and Standing Orders in Texas Section 8.3: Corresponding Responsibility & Red Flags of Diversion Section 8.4: Treatment of Substance Use Disorders

9 Chapter 9: Dispensing Standards & Generic Substitution

Section 9.1: Texas Generic Substitution Law Section 9.2: Patient Counseling and Drug Utilization Review Requirements Section 9.3: Prescription Labeling Requirements in Texas Section 9.4: Poison Prevention Packaging Act & Child-Resistant Containers

10 Chapter 10: Prescription Refills, Transfers & Emergency Dispensing

Section 10.1: Prescription Refill Refusal & Professional Judgment Section 10.2: Prescription Transfer Rules Section 10.3: Emergency Refills (72-hour rule & 30-day natural disaster rule) Section 10.4: Return and Reuse of Prescription Medications

11 Chapter 11: Pharmacy Operations, Security & Recordkeeping

Section 11.1: Pharmacy Security, Alarms & Delivery of Drugs in Texas Section 11.2: General Recordkeeping & Document Retention Requirements Section 11.3: Controlled Substance Inventories Section 11.4: Disposal and Destruction of Controlled Substances

12 Chapter 12: Compounding Standards (Sterile & Non-Sterile)

Section 12.1: Non-Sterile Compounding Regulations Section 12.2: Sterile Compounding Regulations Section 12.3: Hazardous Drug Handling Section 12.4: Compounding Recordkeeping & Quality Control

13 Chapter 13: Specialized Pharmacy Practice & Public Safety

Section 13.1: Collaborative Practice Agreements & Drug Therapy Management Section 13.2: Pharmacist Immunization Authority & Protocol Requirements Section 13.3: Automated Dispensing Devices (Class A, C, and remote sites) Section 13.4: Public Health Laws (HIPAA, OBRA-90, DSCSA Drug Track and Trace)

Section 8.1: Texas Prescription Monitoring Program Reporting & Database

Key Takeaways Explain This Topic AI

The Texas Prescription Monitoring Program (PMP) is administered by the Texas State Board of Pharmacy (TSBP) and tracks Schedule II-V controlled substances.

Dispensing data must be reported to the PMP by the next business day after the prescription is completely filled.

Pharmacies that do not dispense any controlled substances for 7 consecutive days must submit a zero-report (null report).

Mandatory queries of the PMP are required for pharmacists and prescribers before dispensing or prescribing opioids, benzodiazepines, barbiturates, or carisoprodol (Soma).

Exceptions to the mandatory lookup include patients with cancer, those in hospice/palliative care, and documented system outages.

Last updated: July 2026

Section 8.1: Texas Prescription Monitoring Program Reporting & Database

The Texas Prescription Monitoring Program (PMP) is a highly regulated database designed to collect, monitor, and analyze controlled substance prescription data in Texas. Administered by the Texas State Board of Pharmacy (TSBP) , the PMP is one of the most critical tools used by state regulators and pharmacists to combat controlled substance diversion, abuse, and doctor shopping. Understanding the strict reporting timelines, mandatory lookup triggers, and legal exceptions is essential for passing the Texas MPJE.

Regulatory Scope & History

Prior to September 1, 2016, the PMP was operated by the Texas Department of Public Safety (DPS). However, to integrate prescription monitoring more closely with clinical practice, the Texas Legislature transferred administration of the program to the TSBP. The program tracks all outpatient prescriptions for controlled substances in Schedules II, III, IV, and V that are dispensed by a pharmacy in Texas or to a resident of Texas.

Pharmacy Reporting Requirements

Every pharmacy that holds an active Texas pharmacy license and dispenses controlled substances to Texas patients must transmit dispensing data to the PMP. This includes community, hospital outpatient, and mail-order pharmacies.

Who Must Report?

Class A (Community) Pharmacies : Dispensing outpatient prescriptions directly to patients.

Class C (Institutional/Hospital) Pharmacies : While inpatient administration is exempt, Class C pharmacies must report controlled substances dispensed to patients as discharge prescriptions or outpatient prescriptions (e.g., from an emergency department or clinic).

Class E (Non-resident/Out-of-State) Pharmacies : Must report controlled substances dispensed and shipped to patients residing in Texas, regardless of where the pharmacy is physically located.

Reporting Timeline

Dispensing data must be reported to the PMP no later than the next business day after the date the prescription is completely filled (dispensed). A prescription is considered filled when the container is labeled, the drug is packaged, and the order is marked as ready for delivery or pickup.

The Zero-Reporting (Null Report) Rule

If a pharmacy does not dispense any controlled substances in a consecutive 7-day period , it must submit a "zero report" (also known as a "null report") through the PMP clearinghouse (currently AWARxE). This informs the board that the pharmacy is active but has not dispensed controlled substances, rather than experiencing a transmission or technical failure. Failure to submit controlled substance data or a zero report within the required timeframe constitutes a violation of TSBP rules and can lead to administrative penalties, including fines and license suspension.

Mandated PMP Data Elements

The PMP requires transmission of specific, detailed fields for every controlled substance transaction. This ensures accurate patient profiles and auditing capability.

Category Required Data Elements

Pharmacy Information Pharmacy's DEA number, National Provider Identifier (NPI), and pharmacy license number.

Prescription Details Prescription number, date issued (written by the prescriber), and date filled (dispensed).

Drug Information National Drug Code (NDC) number, quantity dispensed, and estimated days' supply.

Patient Information Full name, physical address (including city, state, zip), date of birth, and gender.

Prescriber Information Prescriber's DEA registration number and NPI.

Transaction Information Method of payment (e.g., commercial insurance, Medicaid, Medicare, cash, or self-pay).

Mandatory PMP Query (The "Mandatory Lookup" Rule)

Effective March 1, 2020 , Texas law requires all prescribers (except veterinarians) and pharmacists to query the Texas PMP database before prescribing or dispensing specific controlled substances.

Trigger Substances (Mnemonic: OBBC)

A PMP lookup is mandatory before prescribing or dispensing:

  • O pioids
  • B enzodiazepines
  • B arbiturates
  • C arisoprodol (Soma)

The lookup is designed to identify "red flags" of potential abuse, duplication of therapy, or drug diversion prior to the drug leaving the pharmacy.

Documenting Compliance

Pharmacists must access the PMP database and review the patient's history. If a pharmacist cannot access the PMP, or if a mandatory query is not performed, the pharmacist must document the reason in the pharmacy's records. Failure to perform a mandatory query is a key focus of TSBP audits.

Legal Exemptions to the Mandatory PMP Query

Texas law recognizes specific clinical situations where a PMP query is either impractical or medically unnecessary. Pharmacists and prescribers are exempt from the mandatory query requirement in the following scenarios:

Cancer and Palliative Care : The patient has been diagnosed with cancer or is receiving hospice, end-of-life, or palliative care. The diagnosis or care status must be noted on the prescription, or the pharmacist must verify this information with the prescriber.

Inpatient Administration : The controlled substance is administered to a patient receiving inpatient care at a hospital, nursing home, or intermediate care facility. This exemption applies because inpatient administration is heavily documented and supervised within the facility.

Emergency/System Outages : Access to the PMP is blocked by a technology or system outage (e.g., database downtime, internet failure at the pharmacy) or due to a governor-declared natural disaster. In these cases, the pharmacist must document the attempt to access the PMP and the specific reason for the outage.

PMP Confidentiality & Access Restrictions

Because the PMP contains highly sensitive, protected health information, access is strictly regulated. Unauthorized access or disclosure of PMP data is a state jail felony.

Who Can Access PMP?

Licensed pharmacists and prescribers (and their authorized delegates) for clinical purposes.

TSBP investigators and representatives of other health licensing boards (e.g., Texas Medical Board).

Law enforcement officers, but only if they are conducting an active, open investigation and obtain a search warrant or subpoena.

Strict Prohibitions :

Pharmacists may never perform a search on themselves, family members, neighbors, or celebrities. Queries must be linked to a legitimate professional relationship for patient care.

Pharmacists cannot print out a PMP profile to hand to a patient or show the screen to the patient. While they can discuss the findings (e.g., "Our records show you filled oxycodone at another pharmacy last week"), distributing the official report is a violation.

Exam Traps & Key Reminders

Warning

The 7-Day vs. Next Business Day Trap : Do not confuse the next business day timeline for reporting actual dispenses with the 7-day timeline for zero reporting. Zero reporting is only for consecutive days where no controlled substances are dispensed at all.

Veterinarian Exemption : Veterinarians are completely exempt from the mandatory query rules. However, they must report the controlled substances they dispense.

Payment Method Reporting : The method of payment is a mandatory reporting element. Cash payments for controlled substances are a key indicator of diversion and are heavily tracked by auditors.